NTRS
49
-3
SWK
64
3
F
35
-4
VMC
62
-7
PNW
60
-6
USB
46
-2
VFC
63
-2
STX
50
-2
INTC
36
8
CMS
54
-4
LB
38
-3
DFS
59
5
DGX
39
-4
KIM
66
2
CFG
54
-4
KMB
33
2
SWKS
36
3
FITB
52
-4
HCA
48
-2
IVZ
52
6
NTRS
49
-3
SWK
64
3
F
35
-4
VMC
62
-7
PNW
60
-6
USB
46
-2
VFC
63
-2
STX
50
-2
INTC
36
8
CMS
54
-4
LB
38
-3
DFS
59
5
DGX
39
-4
KIM
66
2
CFG
54
-4
KMB
33
2
SWKS
36
3
FITB
52
-4
HCA
48
-2
IVZ
52
6
Financhill
Back

Krystal Biotech 10K Form

Sell
34

KRYS
Krystal Biotech

Last Price:
171.61
Seasonality Move:
17.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KRYS News And Ratings

See the #1 stock for the next 7 days that we like better than KRYS

KRYS Financial Statistics

Sales & Book Value

Annual Sales: $50.7M
Cash Flow: $-5.3M
Price / Cash Flow: 0
Annual Sales: $29.22
Price / Book: 6.04

Profitability

EPS (TTM): 3.66000
Net Income (TTM): $105.94M
Gross Margin: $47.61M
Return on Equity: 13.85%
Return on Assets: 12.54%

Krystal Biotech Earnings Forecast

Key Krystal Biotech Financial Ratios

  • The Gross Profit Margin over the past 3 years for KRYS is 93.90%.
  • The Selling, General & Administrative Expenses for KRYS have been equal to 194.09% of Gross Profit Margin.
  • The Research & Development expenses have been 91.58% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of KRYS is 21.56% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Krystal Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KRYS
CUSIP: 501147
Website: krystalbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.5
Quick Ratio: 9.23

Price-to-Earnings

Trailing P/E Ratio: 452.28
Forward P/E Ratio: 30.58

KRYS Technical Analysis vs Fundamental Analysis

Sell
34
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy or a Sell?

  • Krystal Biotech stock is rated a Sell
    The current Krystal Biotech [KRYS] share price is $176.39. The Score for KRYS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.